Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06702007 · ClinicalTrials.gov registry record · Phase 3
Electronic Harm Reduction Treatment for Alcohol
A Phase 3 study of Alcohol Use Disorder and Harm Reduction, sponsored by University of Washington.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06702007 is a Phase 3 study of Alcohol Use Disorder and Harm Reduction that is actively recruiting participants, run by University of Washington. The registered enrollment target is 160 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06702007, a Phase 3 study of Alcohol Use Disorder and Harm Reduction, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to transform a successful, face-to-face harm-reduction treatment (HaRT-A) into a digital format, creating eHaRT-A. This new platform is specifically designed for people who have experienced homelessness and an alcohol use disorder (AUD), living within the framework of permanent, supportive, Housing First (HF) facilities. We hypothesize eHaRT-A will be more effective than the standard HF services in reducing alcohol-related harm and improving the overall quality of life for participants.
Conditions Studied
Interventions
- BEHAVIORAL eHaRT-A
Study Locations (1)
Washington
- Downtown Emergency Service Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2027-08-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06702007
The ClinicalTrials.gov registry entry for NCT06702007 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (51% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which eHaRT-A is the first listed.
NCT06702007 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06702007 about?
NCT06702007 is a clinical study titled "Electronic Harm Reduction Treatment for Alcohol". The goal of this project is to transform a successful, face-to-face harm-reduction treatment (HaRT-A) into a digital format, creating eHaRT-A. This new platform is specifically designed for people who have experienced homelessness and an alcohol use disorder (AUD), living within the framework of per...
What is the current status of trial NCT06702007?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2025-01-20. Estimated completion is 2027-08-31.
What conditions does trial NCT06702007 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Harm Reduction, Housing First (eg. Permanent Supportive Housing).
What interventions are being tested in trial NCT06702007?
The interventions under investigation include: eHaRT-A (BEHAVIORAL).
Who is sponsoring clinical trial NCT06702007?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06702007 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Brenipatide in Participants With Alcohol Use Disorder
RECRUITING · Phase 3
-
Emergency Department-Initiated Medications for Alcohol Use Disorder
RECRUITING · Phase 3
-
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
RECRUITING · Phase 3
-
Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
COMPLETED · Phase 3
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
RECRUITING · Phase 2
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.